Is the Prostate Pill Finally Here?
- 22 October 1992
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 327 (17), 1234-1236
- https://doi.org/10.1056/nejm199210223271709
Abstract
After fulfilling its reproductive role, the prostate mostly causes trouble by virtue of its propensity for benign or malignant cellular proliferation in aging men. Benign prostatic hypertrophy causes symptoms of bladder-outlet obstruction in 50 percent of men 60 years of age or older, and 25 to 30 percent ultimately need surgery. Prostatectomy, mostly by transurethral resection, is excellent therapy, but 15 percent of the men who have this operation are not helped and 5 to 10 percent have postoperative complications.1 Carcinoma of the prostate is the most frequent cancer and the second leading cause of death from cancer among men . . .Keywords
This publication has 6 references indexed in Scilit:
- The Molecular Basis of Steroid 5α-Reductase Deficiency in a Large Dominican KindredNew England Journal of Medicine, 1992
- The Effect of Finasteride in Men with Benign Prostatic HyperplasiaNew England Journal of Medicine, 1992
- Screening for Prostatic Carcinoma with Prostate Specific AntigenJournal of Urology, 1992
- Prostates, Pates, and Pimples: The Potential Medical Uses of Steroid 5α-Reductase InhibitorsEndocrinology and Metabolism Clinics of North America, 1991
- Editorial CommentsJournal of Urology, 1991